Annick Desjardins
0000-0003-3869-8283
Publication & Citation Trends
Most Cited Works
Publications
433 total
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial OA
Cited by 1,093
OpenAlex
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients PDF
Cited by 518
OpenAlex
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032 PDF
Cited by 454
OpenAlex
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma PDF
Cited by 367
OpenAlex
Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma PDF
Cited by 227
OpenAlex
Phase II Trial of Temozolomide Plus O<sup>6</sup>-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma PDF
Cited by 314
OpenAlex
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
Cited by 227
OpenAlex
Research Topics
Glioma Diagnosis and Treatment
(289)
Brain Metastases and Treatment
(85)
Cancer Research and Treatments
(52)
Cancer, Hypoxia, and Metabolism
(48)
Cancer Treatment and Pharmacology
(42)
Frequent Co-Authors
Affiliations
University of Copenhagen
Cedars-Sinai Medical Center
Cleveland Clinic
Siriraj Hospital
Children's Hospital of Philadelphia